Peptide Drug Conjugates Market Size, Share, Trends , Growth To 2033
The global peptide drug conjugates refer to the market for medicinal products that target particular human tissues or cells by combining peptides with medications (often chemotherapeutic treatments). By focusing the medications on the desired target, such as cancer cells, this conjugation increases the treatment\'s efficacy while reducing harm to healthy tissues. PDCs are a cutting-edge method of targeted therapy that uses peptide specificity to enhance drug delivery and lessen adverse effects. There are various varieties of PDCs on the market that are being created to treat chronic ailments, autoimmune diseases, and cancer.